Donor Peripheral Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia - Related Studies

Donor Peripheral Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia

This study is ongoing, but not recruiting participants.

Study NCT00031655. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Leukemia

2	Additional conditions recognized in this trial
		Leukemia, Lymphoid
		Precursor Cell Lymphoblastic Leukemia-Lymphoma

3	More general conditions related to this trial
		Immune System Diseases
		Immunoproliferative Disorders
		Lymphatic Diseases
		Lymphoproliferative Disorders
		Neoplasms
		Neoplasms by Histologic Type

4	Interventions listed in this trial
		cyclosporine
		fludarabine phosphate
		mycophenolate mofetil
		therapeutic allogeneic lymphocytes
		radiation therapy

5	Additional drug interventions recognized in this trial
		Cyclosporins
		Fludarabine
		Fludarabine monophosphate

6	More general drug interventions related to this trial
		Anti-Infective Agents
		Antifungal Agents
		Antimetabolites
		Antimetabolites, Antineoplastic
		Antineoplastic Agents
		Antirheumatic Agents
		Dermatologic Agents
		Enzyme Inhibitors
		Immunologic Factors
		Immunosuppressive Agents
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

7	Sponsors listed in this trial
		Fred Hutchinson Cancer Research Center
		National Cancer Institute (NCI)